SUMMARY A patient suffering from severe and continuous muscular spasms is presented. The condition has been classified as the stiff man syndrome and is the first case recorded of the condition in a young African girl. The electrophysiological, biochemical, histochemical, and ultramicroscopic aspects of this disorder have been studied. The spasm appears to be related to overproduction of brain noradrenaline.
In 1956 Moersch and Woltman published a paper in which they described a male patient of 49 years who exhibited a combination of fluctuating muscular rigidity and spasm. They named the condition the stiff man syndrome and at the same time reported their findings on 13 patients with similar complaints. Of the 13, four were females, and it was thus no surprise when in 1958 Asher with his accomplished literary style and humour, published his paper on "A woman with stiff man syndrome". As the average age of onset of these patients was approximately 40 years, we thought that it would be of interest to present this particular patient because of her youth and the exceptionally severe state of muscular spasm. It is the first report of the condition occurring in a young girl and in a black patient of African parentage.
Case report
The patient, an 8 year old black girl ( Fig. 1) , gave a history of progressive disability which extended over a period of 18 months. The condition, as far as could be determined, began with muscle stiffness and spasms which affected the trunk and proximal muscles of upper and lower extremities. This slowly spread to the peripheral musculature. The severity of the spasms gradually increased up to the present. The child is now in constant pain and totally immobilised by her illness. No (Fig. 5) . The appearance of the sural nerve was normal (Fig. 6) .
Specific studies on neurotransmitters were performed by estimations of urinary excretion. The usual precautions with regard to diet were adopted for at least 48 hours before vallinyl mandelic acid (VMA) collections which were assayed by the method of Dekirmenjian and Maas (1970) .
As a means of assessing dopamine activity, urinary homovanillic acid (HVA) was assayed according to the method of Dziedzic et al. (1972) . Metanephrine (ME) and normetanephrine (NME), the excretory products of epinephrine (adrenaline) and norepinephrine (noradrenaline) respectively were assayed by the method of Taniguchi et al. (1964) . 3 Methoxy-4-hydroxy-phenyl glycol (MHPG) was assayed according to the method of Bonsnes and Taussky (1945) . MHPG estimations were carried out as this substance is reputed to give an index of brain noradrenaline production. All specimens were correlated with renal function by way of creatinine clearance: VMA, ME, NME, and HVA levels were normal. The excretory levels were matched with those of a healthy inpatient of similar age and sex who was recovering from a fractured thigh. The present patient's urine contained MHPG 1,950-1-105 mg/24 hr. The control patient produced 1,406+4-84 mg/24 hr. Our patient's MHPG levels were higher than the levels quoted by Schmidt et al. (1975) Physiotherapy was started and the contractures were slowly beginning to lengthen when the parents removed the child from hospital, and she has not been seen or heard of since.
Discussion
The stiff man syndrome as described by Moersch and Woltman (1956) may deteriorate to a point where the patient's body may be distorted by painful continuous muscle spasm. The spasms, as in our patient, increased in severity in response to sensory or emotional stimuli and attempts to move the muscles either actively or passively evoked a most painful reaction. The spasms are involuntary in nature and are seen as violent and painful contractions in both agonists and antagonists. In most cases the proximal muscles are involved earlier and more severely than the distal, and the legs tend to be involved more than the arms. The ultimate posture of the body is severely distorted because of the pull of the more powerful muscles. The abnormal muscle activity makes walking impossible and the patient tends to fall and, to quote from Moersch and Woltman, "falls like a wooden man" or "like a wax dummy." They are unable to sit because the trunk and thighs constitute what was described by Martinelli et al. (1978) The absence of electromyographic evidence of muscle cramp excluded the syndrome of progressive muscle spasm with alopecia and diarrhoea (Satoyoshi, 1978) . The Renshaw cell system suppresses excitability and overactivity of the motor neurones by reducing the rate of discharge, and in so doing prevents synchronous activity. These recurrent axon collaterals are acetylcholine-dependent and as such their activity is enhanced by neostigmine. As with the case of Olafson et al. (1964) , our patient showed no response to large therapeutic doses of this acetylcholinesterase inhibitor, negating defective activity at this level.
The spasms of stiff man syndrome bear a marked similarity to strychnine poisoning where the hyperactive state is presumed to be caused by the lack of suppressive activity of the spinal glycinergic interneuronal system. Tarlov (1959, 1963) were able to produce experimentally (1947) demonstrated the beneficial effect of glycine on this type of muscle spasm and the hind limb rigidity in rats induced by ischaemia was shown to be relieved by glycine administration (Stem and Hadzovic, 1970) . Schmidt et al. (1975) used glycine in the treatment of stiff man syndrome without success, and our patient was given oral glycine in a dose o-f 15 g daily on three consecutive days without clinical improvement. These results support the findings of Schmidt et al. (1975) in establishing that it is unlikely that the glycinergic spinal inhibitory interneuronal system is responsible for the neuronal malfunction in stiff man syndrome unless this system be so pathologically damaged as to be unresponsive. This hypothesis is negated by the absence of pathological findings and by the clinical response observed with other pharmacolo-gical agents.
The dopamine and peripheral catecholinergic systems were considered normal on the basis of excretory studies involving HVA, ME, NME, and VMA-ME, NME, and VMA are derived fro-m peripheral adrenaline and noradrenaline, with HVA being the excretory product of the dopamine system. MHPG derived from central or brain noradrenaline was raised. This is in contrast to the findings in Parkinson's disease where peripheral adrenaline of adrenal origin is increased and is reduced by the administration of levodopa (Stoica and Enulescu, 1978) . Levodopa aggravated the spasms of stiff man syndrome and is known to lower brain concentration of S-adenosylmethionine. This substance is necessary for the transfer of methyl groups in the formation of adrenaline from noradrenaline (Chalmers et al., 1971 ) thus reducing adrenaline formation and increasing noradrenaline concentration. This alteration may account for the deterioration of the symptoms in stiff man syndrome on L-dopa. The therapeutic effect of diazepam in the stiff man syndrome was described by Howard (1963) , and this has helped with the localisation of the dysfunction. Diazepam reduces the level of excitation of both spinal and brain catecholaminergic neurones and increases the levels of gamma aminobutyric acid (GABA). Baclofen, a centrally active GABA derivative, has some effect in reducing spasticity and also reduces the intensity of the spasms in stiff man syndrome. Underactivity of the GABA system as the basic defect in the stiff man syndrome is largely negated, however, by the absence of response to the administration of dipropylacetate. Dipropylacetate increases GABA concentration in the brain (Schmidt et al., 1975) . This investigation confirms the work of Schmidt et al. (1975) 
